The Innovative Health Initiative (IHI) er et offentlig-privat partnerskap mellom EU og MedTech Europe, Efpia, EuropaBio, Cocir, Vaccines Europe. Melanor er medlem i MedTech Europe, og initiativet lanseres 26. januar.
The Innovative Health Initiative (IHI) aims to build on the successes of the Innovative Medicines Initiative (IMI) and will hold a launch event in a virtual setting on Wednesday, January 26th, from 10:30am to 1:00pm. The event will be broken up into two sessions:
In the first session, IHI Executive Director Dr Pierre Meulien will present IHI and explain why we are launching a new European partnership for health. He will also describe what's new compared to the Innovative Medicines Initiative (IMI), and what will stay the same. IHI staff will then present opportunities for stakeholders to get involved in IHI, for example by applying to become a member of the IHI Science and Innovation Panel (SIP), or by becoming an expert evaluator. They will also offer a preview of the draft topics under consideration for inclusion in the first IHI call for proposals.
The second session will feature a high-level discussion during which representatives of the IHI partners, namely the European Commission, the European Parliament, COCIR, EFPIA, Vaccines Europe, EuropaBio and MedTech Europe, will present their vision for IHI. Both sessions will include time for questions from participants.
IHI warmly encourages small and medium-sized enterprises, patient organisations, regulatory authorities, academic teams, industry, hospitals and other organisations with an interest in IHI projects to take part in the launch event.
Registration will open shortly and the preliminary agenda is available via the IHI website at https://www.ihi.europa.eu/news-events/events/introducing-innovative-health-initiative-europes-new-partnership-health
